Seminario Científico “Study of the efficacy of intravenous BCG to subvert tumor-induced myelopoiesis alterations and the impact on lung cancer”
- Este evento ha pasado.
El próximo Martes 8 de marzo de 2022 de 9:00 a 10:00 horas se va a celebrar el Seminario Científico “Study of the efficacy of intravenous BCG to subvert tumor-induced myelopoiesis alterations and the impact on lung cancer”.
Lugar:
Evento Online
Inscríbete